Sansone et al v. Sanofi S.A. et al
| Thomas Sansone and Anna Sansone |
| Sanofi-Aventis U.S. LLC., Chattem Inc., Sanofi S.A., Sanofi US Services Inc., GlaxoSmithKline, LLC. and Boehringer Ingelheim Pharmaceuticals, Inc. |
| 1:2020cv00239 |
| March 3, 2020 |
| US District Court for the Northern District of New York |
| Therese Wiley Dancks |
| Thomas J McAvoy |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 Diversity-Personal Injury |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 26, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 4 JPMDL Conditional Transfer Order #6. Opposition period has expired with no objections filed. ORDER TRANSFERRING CASE to Southern District of Florida for inclusion into MDL-2924 ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION. Case to be assigned to the Hon. Robin L. Rosenberg, U.S. District Judge. (plp) |
| Case transferred electronically to Southern District of Florida for inclusion into MDL-2924. (plp) |
| Case transferred from New York Northern has been opened in Southern District of Florida as case 9:20-cv-80510, filed 03/26/2020. (plp) |
| Filing 3 G.O. 25 FILING ORDER ISSUED: Initial Conference set for 6/3/2020 11:00 AM in Syracuse before Magistrate Judge Therese Wiley Dancks. Civil Case Management Plan must be filed and Mandatory Disclosures are to be exchanged by the parties on or before 5/27/2020. All conferences are conducted by telephone. Plaintiff's attorney will initiate the call (unless the Court directs differently) and shall contact Judge Dancks' Chambers at 315-234-8618 (a dedicated line solely for telephone conferences) once all parties are on the line. Counsel may use a teleconferencing service for assistance initiating conference calls to the Court. For cases involving pro se parties, the Court will initiate the call for the Rule 16 Conference. Pro se parties are instructed to provide the Court with a telephone number where they may be reached for a conference call. (Pursuant to Local Rule 26.2, mandatory disclosures are to be exchanged among the parties but are NOT to be filed with the Court.) (mgh) |
| Filing 2 Summons Issued as to Boehringer Ingelheim Pharmaceuticals, Inc., Chattem Inc., GlaxoSmithKline, LLC., Sanofi S.A., Sanofi US Services Inc., Sanofi-Aventis U.S. LLC. (Attachments: #1 Summons Issued as to Sanofi-Aventis U.S. LLC, #2 Summons Issued as t o Sanofi US Services, Inc., #3 Summons Issued as to Chattem, Inc., #4 Summons Issued as to Boehringer Ingelheim Pharmaceuticals, Inc., #5 Summons Issued as to GlaxoSmithKline, LLC)(mgh) |
| Filing 1 COMPLAINT against Boehringer Ingelheim Pharmaceuticals, Inc., Chattem Inc., GlaxoSmithKline, LLC., Sanofi S.A., Sanofi US Services Inc., Sanofi-Aventis U.S. LLC. (Filing fee $400 receipt number 5048870) filed by Anna Sansone, Thomas Sansone. (Attachments: #1 Civil Cover Sheet)(mgh) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
